cerrar
Tagged with IoT

Zhenkun Ma – CEO, TenNor Therapeutics, China
Zhenkun Ma, founder and CEO of TenNor Therapeutics, shares his cross-sectorial experiences in Big Pharma, biotech and non-profit organization that led…

China’s CARsgen Therapeutics Wins US FDA Orphan Drug…
The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics' CAR-T cell therapy CT053 for multiple myeloma…

Scott Li – Deputy Manager, H Spectrum, Taiwan
Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique…

Shanghai’s STAR Board Lures Biotechs Away From Hong Kong
Competition is heating up among Asian stock exchanges hoping to lure the hottest prospects in Chinese biotech to list there. The newest competitor,…

5 More Biotechs to Watch in China
Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making waves in the world’s…

Uli Hacksell – CEO & President, Medivir, Sweden
Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical…

Somvong Tragoonrung – Executive Director, BIOTEC, Thailand
Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current…

Kai Lamottke – Co-Founder, Managing Director (Germany)…
Dr Kai Lamottke, co-founder and MD of Bicoll GmbH, Munich, and since 2001, GM and board member of Bicoll Biotechnology (Shanghai) Co. Ltd discusses…

Taiwan Biotech Snapshot
Taiwan's biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the island's total biopharmaceutical market,…

HB Chen – President, TaiwanBio Therapeutics
HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique…

5 People You Should Know in Taiwanese Life Sciences
Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and…

Bayer: Betting Big on Cell & Gene Therapy
Bayer's latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here